Abstract
The presence of cancer of the prostate does not mean that a patient will succumb to the disease. In fact, prior to the advent of prostate-specific antigen (PSA) testing, the cause of death in 50% of men with detectable extraglandular cancer was intercurrent disease. No studies have conclusively demonstrated a definitive benefit of surgery or radiation over simple observation; therefore treatment complications must absolutely be restricted to a bare minimum while demonstrating curative effect. This review presents a balanced perspective on the management of prostate cancer which results from non-adversarial, extensive, and continuous interactions between two very active Departments (Urology and Radiation Oncology). Such a multidisciplinary approach fosters relevant research projects and ultimately benefits patient care.
Translated title of the contribution | A balanced surgical-radiotherapeutic approach for management of prostate cancer with emphasis on PSA |
---|---|
Original language | French |
Pages (from-to) | 173-184 |
Number of pages | 12 |
Journal | Journal d'urologie |
Volume | 100 |
Issue number | 4 |
State | Published - Jan 1 1994 |
Keywords
- PSA
- prostate cancer
- radiotherapeutic approach
ASJC Scopus subject areas
- Urology